.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
UBS
Cerilliant
Fish and Richardson
Chinese Patent Office
Julphar
AstraZeneca
US Department of Justice
Queensland Health
Mallinckrodt

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077204

« Back to Dashboard
NDA 077204 describes CHOLESTYRAMINE, which is a drug marketed by Par Pharm, Teva, Ani Pharms Inc, Sandoz, Ivax Sub Teva Pharms, Zydus Pharms Usa Inc, and Teva Pharms, and is included in ten NDAs. It is available from six suppliers. Additional details are available on the CHOLESTYRAMINE profile page.

The generic ingredient in CHOLESTYRAMINE is cholestyramine. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

Summary for NDA: 077204

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 077204

Mechanism of ActionBile-acid Binding Activity

Suppliers and Packaging for NDA: 077204

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHOLESTYRAMINE
cholestyramine
POWDER;ORAL 077204 ANDA Par Pharmaceutical, Inc. 49884-465 49884-465-65 60 PACKET in 1 CARTON (49884-465-65) > 9 g in 1 PACKET (49884-465-64)
CHOLESTYRAMINE
cholestyramine
POWDER;ORAL 077204 ANDA Par Pharmaceutical, Inc. 49884-465 49884-465-66 378 g in 1 CAN (49884-465-66)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/PACKET
Approval Date:Aug 26, 2005TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/SCOOPFUL
Approval Date:Aug 26, 2005TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
McKesson
Teva
Healthtrust
Chubb
Covington
Fuji
AstraZeneca
Deloitte
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot